A dynamic assessment of medication‐taking behavior during pregnancy and postpartum: should cART adherence be reinforced during postpartum?

Abstract

This study compared adherence (persistence and execution) during pregnancy and postpartum in HIV‐positive women having taken part in the adherence‐enhancing program of the Community Pharmacy of the Department of Ambulatory Care and Community Medicine in Lausanne between 2004 and 2012. This interdisciplinary program combined electronic drug monitoring and semi‐structured, repeated motivational interviews. This was a retrospective, observational study. Observation period spread over from first adherence visit after last menstruation until 6 months after childbirth. Medication‐taking was recorded by electronic drug monitoring. Socio‐demographic and delivery data were collected from Swiss HIV Cohort database. Adherence data, barriers and facilitators were collected from pharmacy database. Electronic data were reconciled with pill‐count and interview notes in order to include reported pocket‐doses. Execution was analyzed over 3‐day periods by a mixed effect logistic model, separating time before and after childbirth. This model allowed us to estimate different time slopes for both periods and to show a sudden fall associated with childbirth. Twenty‐five pregnant women were included. Median age was 29 (IQR: 26.5, 32.0), women were in majority black (n = 17,68%) and took a cART combining protease and nucleoside reverse transcriptase inhibitors (n = 24,96%). Eleven women (44%) were ART‐naïve at the beginning of pregnancy. Twenty women (80%) were included in the program because of pregnancy. Women were included at all stages of pregnancy. Six women (24%) stopped the program during pregnancy, 3 (12%) at delivery, 4 (16%) during postpartum and 12 (48%) stayed in program at the end of observation time. Median number of visits was 4 (3.0, 6.3) during pregnancy and 3 (0.8, 6.0) during postpartum. Execution was continuously high during pregnancy, low at beginning of postpartum and increased gradually during the 6 months of postpartum.imageMajor barriers to adherence were medication adverse events and difficulties in daily routine. Facilitators were motivation for promoting child‐health and social support. The dramatic drop and very slow increase in cART adherence during postpartum might result in viral rebound and drug resistance. Although much attention is devoted to pregnant women, interdisciplinary care should also be provided to women in the community during first trimester of postpartum to support them in sustaining cART adherence.